SCHEMBL6770710

SCHEMBL6770710

CC(C)Cc1nn(-c2cccc(Cl)c2)c2c1C(=O)CCC2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 4/20 0.50
LMNA P02545 1/20 0.50
TSHR P16473 1/20 0.50
HTT P42858 1/20 0.50
ALDH1A1 P00352 4/20 0.47
MAPT P10636 1/20 0.47
OPRM1 P35372 1/20 0.46
KDM4E B2RXH2 3/20 0.39
TP53 P04637 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HPGD P15428 1/20 0.38
HTR6 P50406 1/20 0.37
KMT2A Q03164 2/20 0.37
MAPK1 P28482 1/20 0.37
ATM Q13315 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA4 P22748 1/20 0.36
CA9 Q16790 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6776683 0.87 LMNA (0.46) SRCLMNATSHRHTTALDH1A1
SCHEMBL6165127 0.87 ALDH1A1 (0.43) SRCLMNATSHRHTTALDH1A1
SCHEMBL6769419 0.87 SRC (0.47) SRCLMNATSHRHTTALDH1A1
SCHEMBL6771081 0.85 ALDH1A1 (0.58) SRCLMNATSHRHTTALDH1A1
SCHEMBL6769466 0.82 SRC (0.53) SRCLMNATSHRHTTALDH1A1
SCHEMBL6770491 0.82 OPRM1 (0.51) SRCLMNAALDH1A1OPRM1KMT2A
SCHEMBL6769517 0.82 SRC (0.39) SRCLMNAALDH1A1KDM4ETP53
SCHEMBL6769828 0.82 OPRM1 (0.67) SRCLMNATSHRHTTALDH1A1
SCHEMBL6772419 0.81 SRC (0.39) SRCLMNAALDH1A1KDM4ETP53
SCHEMBL6767118 0.80 HTT (0.40) SRCLMNATSHRHTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed